Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Ekf Diagnostics Holdings Plc LSE:EKF London Ordinary Share GB0031509804 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.40 0.54% 75.00 74.40 75.80 77.00 74.40 77.00 105,651 16:35:09
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 65.3 15.4 2.5 30.6 341

EKF Diagnostics Holdings PLC Result of AGM

19/05/2021 12:58pm

UK Regulatory (RNS & others)


Ekf Diagnostics (LSE:EKF)
Historical Stock Chart


From May 2021 to Jul 2021

Click Here for more Ekf Diagnostics Charts.

TIDMEKF

RNS Number : 1742Z

EKF Diagnostics Holdings PLC

19 May 2021

EKF Diagnostics Holdings plc

("EKF", the "Company" or the "Group")

Result of AGM

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed point-of-care business, announces that at the Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed.

The results of the AGM will be made available on the Company's website: https://www.ekfdiagnostics.com/

 
EKF Diagnostics Holdings plc                                   www.ekfdiagnostics.com 
Christopher Mills, Non-executive Chairman                   Tel: +44 (0) 29 2071 0570 
Julian Baines, CEO 
Richard Evans, FD & COO 
 
N+1 Singer                                                         Tel: 020 7496 3000 
Aubrey Powell / George Tzimas / Tom 
 Salvesen 
Walbrook PR Limited                   Tel: +44 (0) 20 7933 8780 or ekf@walbrookpr.com 
Paul McManus / Lianne Cawthorne              Mob: +44 (0) 7980 541 893 / +44 (0) 7584 
                                                                              391 303 
 
 

About EKF Diagnostics Holdings plc ( www.ekfdiagnostics.com )

EKF is a leading point-of-care diagnostics and central laboratory assay manufacturer with an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose and lactate analysers in regular use across more than 100 countries. EKF specialises in developing tests for use in anemia and diabetes diagnosis and management, as well as providing a portfolio of reagents for use in clinical chemistry analysers.

EKF specialises in the development, production and worldwide distribution of point-of-care analyzers and clinical chemistry reagents for use in hospital and research laboratories, doctor's offices, blood banks and for in-field anaemia screening programmes. EKF is also a bulk manufacturer of enzymes and has custom manufacturing facilities in the USA for a variety of life science products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGSFIFFUEFSEII

(END) Dow Jones Newswires

May 19, 2021 07:58 ET (11:58 GMT)

1 Year Ekf Diagnostics Chart

1 Year Ekf Diagnostics Chart

1 Month Ekf Diagnostics Chart

1 Month Ekf Diagnostics Chart
ADVFN Advertorial
Your Recent History
LSE
EKF
Ekf Diagno..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210731 21:39:00